[{"Assets_0_Q1_USD":57794000.0,"CommonStockSharesOutstanding_0_Q1_shares":21401828.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-8183000.0,"NetIncomeLoss_1_Q1_USD":-6980000.0,"StockholdersEquity_0_Q1_USD":47994000.0,"Ticker":"VRDN","CIK":"1590750","name":"MIRAGEN THERAPEUTICS, INC.","OfficialName":"Viridian Therapeutics Inc. Common Stock","form":"10-Q","period":"20170331","fy":"2017.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"445189274.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20170511"}]